Features

For the second year in a row, the annual Drug Delivery to the Lungs meeting drew more than 850 OINDP specialists and 110 exhibitors to the Edinburgh International Conference Centre to catch up on the latest in inhalation research and technology. Much of the meeting focused on issues of sustainability, with discussion centered on reducing the carbon footprint of … [Read more...] about DDL 2019 highlighted sustainability issues in the inhaled drug delivery industry

By Jason A Suggett, Mark W Nagel, Dominic P Coppolo, and Jolyon P Mitchell A wide spectrum of options is available for delivering inhaled medications by nebulization.  The challenge, either for a developer considering which delivery option to use for their new formulation, or for a clinician prescribing therapy that will be funded either privately or through … [Read more...] about Nebulization therapy: finding the optimum combination of performance, features, and affordability

The 2019 iteration of the Drug Delivery to the Lungs conference, which will take place December 11-13, marks the event's 30th year and will be the 15th DDL meeting held at the Edinburgh International Conference Centre. From its initial 1989 gathering of 100 delegates at the GlaxoSmithKline site in Ware, UK, the meeting has grown significantly, drawing over 850 … [Read more...] about DDL2019 to celebrate 30 years of Drug Delivery to the Lungs

Led by inhaler device platform designer and supplier Merxin and by Nanopharm, a CRO specializing in inhaled and nasal drugs, a group of companies that offer products and services for OINDP development has come together to put on a new event series called Inspire Me. The first event will take place on June 4 and 5, 2019 in San Francisco, CA, USA, with the first day … [Read more...] about OINDP companies get together to create new event series

Over 500 OINDP specialists attended RDD Europe 2019 in Estoril, Portugal, May 7-10, making the conference the biggest RDD Europe meeting ever, the organizers said. Carolyn Penot of Aptar Pharma, which co-organizes RDD Europe said, "We've had great feedback from all of the attendees about Estoril, that it's a great place to come for a meeting, and it's been our most … [Read more...] about RDD Europe 2019 addressed challenges to the status quo

A Q&A with Jamie Clayton of Freeman Technology What is dynamic powder testing and why is it valuable for DPI development? Dynamic powder testing is a modern technique developed specifically to generate process relevant powder properties where dynamic powder properties, including basic flowability energy (BFE) and specific energy (SE), are generated from … [Read more...] about Using dynamic powder testing in DPI development

RDD Europe 2019 will take place May 7-10 at the Estoril Congress Center outside of Lisbon. Organizers expect approximately 500 inhaled and nasal drug specialists from industry, academia, and regulatory agencies to attend this year's meeting. Richard Dalby of RDD Online, which co-organizes the meeting with Aptar Pharma, notes that one of the current hot topics of … [Read more...] about RDD Europe 2019 to address Brexit and other hot topics

One of the distinguishing features of RDD Europe is the workshop session, when a dozen companies offer 60-minute presentations on their latest technology, products, or services to small groups of 10-40 people at a time. Each workshop is presented 3 times during the session, and RDD Europe attendees have the opportunity to select 3 of the 12 sessions. "The … [Read more...] about RDD Europe workshop topics: new propellant, devices, and tech

The annual Drug Delivery to the Lungs meeting once again experienced significant growth in attendance and sponsorship, as DDL 2018 drew more than 850 attendees and 110 exhibitors to the Edinburg International Conference Centre. Many of the talks focused on the need for OINDP specialists to better deal with the complexity inherent in aerosol drug delivery and to … [Read more...] about DDL 2018 in review